ArticleIndian journal of endocrinology and metabolism

Efficacy and Safety of Canagliflozin 300 mg in Overweight and Obese Type 2 Diabetes Mellitus Patients in a Real-world Setting: COLOR Study.

Pankaj Aneja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.